Medicare’s Drug Price Talks with Manufacturers Set to Have Muted Financial Impact in First Round

Medicare’s Drug Price Talks with Manufacturers Set to Have Muted Financial Impact in First Round

Medicare Negotiates to Make Costly Drugs More Affordable for Older Americans Introduction Medicare is taking a step to negotiate prices for ten different drugs with manufacturers in an effort to increase affordability for older Americans. This move is opposed by the pharmaceutical industry, but analysts believe that the financial impact on manufacturers will be limited,…

End of content

End of content